Clinical trial
Gene Expression in MS Patients Before and During Treatment With Interferon-beta
NCT00202384 · S. Andrea Hospital, Other · Terminated
Key facts
| NCT number | NCT00202384 |
|---|---|
| Title | Gene Expression in MS Patients Before and During Treatment With Interferon-beta |
| Official title | Gene Expression in MS Patients Before and During Treatment With High-dose Interferon Beta: Prospective Study for the Identification of Predicting Factors of Therapeutic Response. |
| Lead sponsor | S. Andrea Hospital, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Enrollment | 600 |
| Start date | Nov 1, 2004 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 19, 2018 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: